:

Cian M Hehir1,2, Michael O'Connor2, Iulia Marinescu3,4

  • 1Tissue Engineering Research Group (TERG), Royal College of Surgeons in Ireland, 123 St. Stephen's Green, D02 YN77 Dublin, Ireland.

PubMed
概括

血管化复合性全移植 (VCA) 为复杂的重建需求提供了解决方案,但面临着排斥和免疫抑制等挑战. 监测和治疗方面的进步旨在改善VCA的结果.